Xeruborbactam Disodium (implied program)

About Qpex Biopharma

Qpex Biopharma is a San Diego-based biotech founded in 2018, dedicated to combating antimicrobial resistance through innovative anti-infective therapies. The company employs a science platform focused on improving existing drug classes, targeting underexploited mechanisms, and developing non-antibiotic resistance breakers. As a private, Shionogi-backed entity, it is advancing a pipeline of novel agents designed to treat serious, multidrug-resistant infections, positioning itself in a critical but challenging market with high unmet medical need.

Therapeutic Areas

Other Drug-resistant bacterial infections Drugs